Provided by Tiger Trade Technology Pte. Ltd.

MediciNova

1.50
-0.0709-4.52%
Volume:34.04K
Turnover:50.98K
Market Cap:73.68M
PE:-6.85
High:1.58
Open:1.57
Low:1.43
Close:1.57
52wk High:1.96
52wk Low:1.17
Shares:49.15M
Float Shares:43.50M
Volume Ratio:0.87
T/O Rate:0.08%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.2188
EPS(LYR):-0.2445
ROE:-25.56%
ROA:-16.41%
PB:1.98
PE(LYR):-6.13

Loading ...

MediciNova completes Phase 2 trial last patient visit for MN-001 in NAFLD, hypertriglyceridemia linked to type 2 diabetes

Reuters
·
May 27

Medicinova Announces Completion of Last Patient Last Visit in the Mn-001-Natg-202 Clinical Trial of Mn-001 (Tipelukast)

THOMSON REUTERS
·
May 27

MediciNova Announces Completion of Last Patient Last Visit in the MN-001-NATG-202 Clinical Trial of MN-001 (Tipelukast)

GlobeNewswire
·
May 27

MediciNova Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 15

MediciNova Inc expected to post a loss of 7 cents a share - Earnings Preview

Reuters
·
May 08

MediciNova Is Maintained at Buy by D. Boral Capital

Dow Jones
·
May 04

MediciNova’s peer-reviewed ibudilast study advances clinical translation

TIPRANKS
·
Apr 28

MediciNova plans clinical studies of ibudilast for brain metastases after CNIO findings

Reuters
·
Apr 28

New Peer‑Reviewed Study Reveals Actionable Immune–Microenvironment Target in Brain Metastasis; Medicinova Advances Clinical Translation

GlobeNewswire
·
Apr 28

MediciNova announces annual shareholder meeting

Reuters
·
Apr 18

MediciNova Price Target Announced at $6.00/Share by Maxim Group

Dow Jones
·
Mar 23

MediciNova resumed with a Buy at Maxim

TIPRANKS
·
Mar 23

MediciNova Initiated at Buy by HC Wainwright & Co.

Dow Jones
·
Mar 16

MediciNova executives to meet investors at the 38th Annual ROTH Conference

Reuters
·
Mar 16

MediciNova to Participate at the 38th Annual ROTH Conference

GlobeNewswire
·
Mar 16

MediciNova initiated with a Buy at H.C. Wainwright

TIPRANKS
·
Mar 16

Medicinova, Inc. : H.c. Wainwright Initiates Coverage With Buy Rating

THOMSON REUTERS
·
Mar 16

MediciNova FY2025 net loss widens 9% to USD 12 million

Reuters
·
Mar 11